Source: DGNews | Posted 8 years ago
Betaseron (Interferon Beta-1b) Gains Expanded FDA Labeling Approval for Treating Relapsing Forms of Multiple Sclerosis
Tags:
MONTVILLE, NJ and EMERYVILLE, CA -- March 17, 2003 -- Berlex Laboratories, Inc., the U.S. affiliate of Schering AG, Germany (NYSE: SHR), and Chiron Corporation (Nasdaq: CHIR) today announced that the U.S. Food and Drug Administration (FDA) has approved new labeling for the multiple sclerosis (MS) treatment Betaseron
Comments